FBLN4 Antikörper (AA 331-443) (Biotin)

Produktnummer ABIN1701235

Produktdetails anti-FBLN4 Antikörper (Biotin)

Target: FBLN4 (Fibulin 4 (FBLN4))

Bindungsspezifität: AA 331-443

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FBLN4 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human EFEMP2/Fibulin 4

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Referenzen für anti-FBLN4 Antikörper (Biotin) (ABIN1701235)

Dekker, van Geemen, van den Bogaerdt, Driessen-Mol, Aikawa, Smits: "Sheep-Specific Immunohistochemical Panel for the Evaluation of Regenerative and Inflammatory Processes in Tissue-Engineered Heart Valves." in: Frontiers in cardiovascular medicine, Vol. 5, pp. 105, (2018) (PubMed).

Details zu FBLN4

Target: FBLN4 (Fibulin 4 (FBLN4))

Andere Bezeichnung: EFEMP2/Fibulin 4 (FBLN4 Produkte)

Synonyme: CB257 antikoerper, fbln4 antikoerper, fc56c09 antikoerper, id:ibd2923 antikoerper, sb:cb257 antikoerper, wu:fc56c09.x1 antikoerper, ARCL1B antikoerper, FBLN4 antikoerper, MBP1 antikoerper, UPH1 antikoerper, 0610011K11Rik antikoerper, Fbln4 antikoerper, FIBL-4 antikoerper, Fibulin-4 antikoerper, H411 antikoerper, EGF-containing fibulin-like extracellular matrix protein 2 antikoerper, EGF containing fibulin-like extracellular matrix protein 2b antikoerper, fibulin 4 antikoerper, EGF containing fibulin like extracellular matrix protein 2 antikoerper, epidermal growth factor-containing fibulin-like extracellular matrix protein 2 antikoerper, Efemp2 antikoerper, efemp2b antikoerper, fbln4 antikoerper, EFEMP2 antikoerper

Hintergrund:

Synonyms: EFEMP2, EGF containing fibulin like extracellular matrix protein 2, EGF-containing fibulin-like extracellular matrix protein 2, FBLN 4, FBLN4, FBLN4_HUMAN, FIBL 4, FIBL-4, FIBL4, Fibulin4, Fibulin-4, MBP 1, MBP1, Mutant p53 binding protein 1, Protein UPH1, UPH 1, UPH1, UPH1 protein.

Background: Fibulin proteins contribute to normal development of elastic fiber systems in various types of organs that require elasticity, such as vasculature, lung and skin. Fibulin-4, also known as EFEMP2 (EGF-containing fibulin-like extracellular matrix protein 2), MBP1 or UPH1 is a 443 amino acid secreted protein that contains six EGF-like calcium-binding domains and belongs to the fibulin family. Expressed ubiquitously with highest expression in heart, Fibulin-4 is essential for connective tissue development and elastic fiber formation, and may also play an important role in vascular patterning and collagen biosynthesis. Defects in the gene encoding Fibulin-4 are associated with autosomal recessive cutis laxa type I (CL type I), a connective tissue disorder that is inherited in both an autosomal dominant and an autosomal recessive manner and is characterized by inelastic tissue in all affected areas of the body.

Gen-ID: 30008